Bank Of Montreal Ab Cellera Biologics Inc. Transaction History

Bank Of Montreal

$233 Billion
Q3 2025

A detailed history of Bank Of Montreal transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Bank Of Montreal holds 65,508 shares of ABCL stock, worth $241,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,508

Previous 70,089 6.54%

Holding current value

$241,724

Previous $240,000 37.08%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$3.49 - $5.15 $15,987 - $23,592	-4,581 Reduced 6.54%	65,508 $329,000
Q2 2025 Aug 05, 2025	BUY	$1.93 - $3.8 $42,759 - $84,189	22,155 Added 46.22%	70,089 $240,000
Q1 2025 May 13, 2025	SELL	$2.2 - $3.53 $7,728 - $12,400	-3,513 Reduced 6.83%	47,934 $106,000
Q4 2024 Feb 13, 2025	SELL	$2.48 - $3.15 $16,283 - $20,682	-6,566 Reduced 11.32%	51,447 $150,000
Q3 2024 Nov 13, 2024	BUY	$2.39 - $3.49 $39,086 - $57,075	16,354 Added 39.26%	58,013 $150,000

Q2 2024 Aug 14, 2024	SELL	$2.73 - $4.73 $6,737 - $11,673	-2,468 Reduced 5.59%	41,659 $123,000
Q1 2024 May 13, 2024	BUY	$4.29 - $5.97 $54,414 - $75,723	12,684 Added 40.34%	44,127 $199,000
Q4 2023 Feb 08, 2024	SELL	$3.91 - $5.93 $117,616 - $178,380	-30,081 Reduced 48.89%	31,443 $179,000
Q3 2023 Nov 01, 2023	SELL	$4.6 - $7.95 $13,422 - $23,198	-2,918 Reduced 4.53%	61,524 $283,000
Q2 2023 Aug 02, 2023	BUY	$5.66 - $7.59 $5,688 - $7,627	1,005 Added 1.58%	64,442 $416,000
Q1 2023 Jun 13, 2024	BUY	$7.31 - $11.18 $180,483 - $276,034	24,690 Added 55.95%	68,817 $518,000
Q4 2022 Feb 01, 2023	SELL	$9.48 - $14.52 $789,788 - $1.21 Million	-83,311 Reduced 56.77%	63,437 $642,000
Q3 2022 Nov 10, 2022	SELL	$9.2 - $13.68 $1.76 Million - $2.61 Million	-190,902 Reduced 56.54%	146,748 $1.55 Million
Q2 2022 Aug 11, 2022	BUY	$5.72 - $10.65 $1.2 Million - $2.23 Million	209,148 Added 162.76%	337,650 $3.47 Million
Q1 2022 May 12, 2022	BUY	$7.46 - $14.14 $190,438 - $360,965	25,528 Added 24.79%	128,502 $1.27 Million
Q4 2021 Feb 11, 2022	SELL	$12.99 - $17.73 $162,245 - $221,447	-12,490 Reduced 10.82%	102,974 $1.5 Million
Q3 2021 Nov 12, 2021	BUY	$14.85 - $21.34 $638,163 - $917,065	42,974 Added 59.28%	115,464 $2.25 Million
Q2 2021 Aug 12, 2021	BUY	$20.19 - $34.17 $1.46 Million - $2.48 Million	72,490 New	72,490 $1.55 Million

Others Institutions Holding ABCL

# of Institutions

169

Shares Held

109M

Call Options Held

1.26M

Put Options Held

788K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.05B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account